All posts by imreal

Catalent Expands Biologics Analytical Capabilities with New Laboratories at Center of Excellence in Kansas City, Missouri


Catalent's facility in Kansas City, Missouri

Catalent’s facility in Kansas City, Missouri

Our team at Kansas City serves as a strategic partner for customers of all sizes, and this expansion will allow it to support the increased demand and assay requirements for broad-based and orthogonal analytical CMC services.

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri. The project will see the addition of two new analytical development laboratories to support the growing demands of assay development for both traditional biologic and advanced biologic modality programs.

The first of the two new laboratories will cover approximately 3,500 square feet and will be completed by the end of October 2022, with the second, measuring 3,000 square feet, due to be operational in the first quarter of 2023. The expansion will create approximately 50 new scientific jobs at the site by February 2023.

The additional capacity will increase the capabilities that Catalent has across its network in both standalone services and integrated development programs. In recent months, Catalent has expanded its CMC large molecule analytical services at Kansas City to include additional services in excipient and media components support, extractable and leachable testing, droplet digital PCR technologies (ddPCR), and next-generation sequencing (NGS), to support customers’ growing needs to accelerate programs and meet regulatory requirements.

“The need for timely analytical support in development, characterization and CGMP testing is critical for innovators across the biologics pipeline, with delays affecting the overall time to get new drugs into the clinic, and ultimately to patients,” said Jeremie Trochu, Division Head for BioAnalytics at Catalent. “Our team at Kansas City serves as a strategic partner for customers of all sizes, and this expansion will allow it to support the increased demand and assay requirements for broad-based and orthogonal analytical CMC services for both traditional biotherapeutics and advanced modalities such as antibody-drug conjugates, cell and gene therapies and mRNA vaccines.”

Catalent’s Kansas City facility is a center of excellence for its standalone biologics analytical services business, with over 30 years of experience providing cell-based assays and characterization studies for drug substance, drug products and intermediates, for both innovator and biosimilar products. It also provides a range of integrated services for oral solid dosage forms as well as comprehensive clinical packaging and supply services. In April 2022, Catalent announced the completion of an expansion project to increase capacity and capabilities for producing encapsulated oral solid dose forms at the site.

About Catalent Biologics

For nearly three decades, Catalent Biologics has built capabilities and expertise in development, manufacturing, and analytical services, now spanning new biological entities, biosimilars, plasmid DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. It has developed 600+ antibodies and 80+ recombinant proteins, with 120+ active clinical trials and 16 marketed biotherapeutics use GPEx® cell line engineering technology. An additional 45+ commercially approved products have employed Catalent Biologics’ manufacturing and packaging capabilities.

Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. With a comprehensive cell therapy portfolio and deep expertise in viral vector development, scale-up and manufacturing, Catalent is a full-service partner for plasmid DNA, adeno-associated viral (AAV) and other viral vectors, viral vaccines, iPSCs and autologous and allogeneic cell therapies.

Using advanced technologies and tailored solutions from clinical to commercial supply, Catalent brings better biologic and advanced treatments to patients, faster.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 19,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied™.

Share article on social media or email:

Recipients Of 2022 Congressional Bone Health Champion Award Announced


News Image

The Bone Health and Osteoporosis Foundation (BHOF) is pleased to announce the 2022 recipients of our national award to recognize Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of Americans. The awards are presented annually by BHOF to highlight the importance of bone health and the osteoporosis crisis in the U.S., and the work by national leaders to advance improvements in bone health policy.

The 2022 Congressional Bone Health Champion Award winners are:

Senator Shelley Moore Capito (R-WV): Senator Capito is one of the lead sponsors of the bipartisan legislation, S. 1943, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. She is a leader in supporting many women’s health issues in Congress and has introduced legislation to support them.

Senator Patty Murray (D-WA): Senator Murray is the Chair of the Labor, Health and Human Services, Education and Related Agencies Appropriations panel. This year’s Senate appropriations report for the first time calls for a national education campaign to promote greater education and awareness about bone health and osteoporosis.

Representative Michael Burgess (R-TX): Representative Burgess was one of the original sponsors of H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Dr. Burgess has a longstanding history of support for improving bone health having previously been a member of the House Osteoporosis Caucus.

Representative Linda Sánchez (D-CA): Representative Sánchez is one of the lead sponsors of bipartisan legislation, H.R.3517, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.

“Bone health is crucial to your overall health. Congress needs to prioritize bone health on our nation’s healthcare agenda, and pass legislation to improve bone health awareness, screening and care. We know it will have a dramatic impact on improving quality of life and reducing costly osteoporotic fractures,” said Claire Gill, CEO of the Bone Health and Osteoporosis Foundation

Osteoporosis is a growing yet often ignored health care problem that disproportionately impacts women. Ten million Americans have osteoporosis and 44 million are at high risk of the disease due to low bone density. According to a 2021 report, two million Medicare beneficiaries (about 70 percent women) suffered up to 2.1 million osteoporotic bone fractures in 2016. For women, the risk of any osteoporotic fracture is greater than their risk of a heart attack, stroke or breast cancer combined. The total annual cost for osteoporotic fractures among Medicare beneficiaries was $57 billion in 2018 and is expected to grow to over $95 billion in 2040 without reforms, as the population ages.

# # #

About the Bone Health and Osteoporosis Foundation

The Bone Health and Osteoporosis Foundation, formerly the National Osteoporosis Foundation, is the leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of public and clinician awareness, education, advocacy and research. Established in 1984, BHOF is the nation’s largest health organization dedicated to osteoporosis and bone health.

Share article on social media or email:

Sagora Senior Living Named New Operator for Four Nebraska Communities


Sagora Senior Living is proud to announce that it has been named the operator of four communities in Nebraska

“Our growth allows us to better serve residents and drive positive change in their lives by providing them with an exceptional living experience,” Sagora Senior Living President Bryan McCaleb said.

Sagora Senior Living is now the operator of four senior living communities located in the state of Nebraska effective today, October 20, 2022. The addition of these communities expands Sagora Senior Living’s operations to 61 communities across 12 states.

“We are looking forward to the opportunity to expand our Resident First philosophy and further enrich the lives of seniors,” Sagora Senior Living President Bryan McCaleb said. “Our growth allows us to better serve residents and drive positive change in their lives by providing them with an exceptional living experience.”

Sagora Senior Living has begun to implement its core values and standards in these communities and will continue to do so over the next few months. Each community has been rebranded under the Bailey Pointe name, which serves to reflect the comfortable, home-like atmosphere of these communities while honoring the state’s railroad heritage and the role it played in shaping America.

The newly operated Sagora communities include:

  •     The Windcrest on Van Dorn in Lincoln, Nebraska, now rebranded as Bailey Point Assisted Living at Van Dorn
  •     The Waterford at Miracle Hills in Omaha, Nebraska, now rebranded as Bailey Point Assisted Living at Miracle Hills
  •     The Waterford at Roxbury Park in Omaha, Nebraska, now rebranded as Bailey Point Assisted Living at Roxbury Park
  •     The Waterford at Woodbridge in Plattsmouth, Nebraska, now rebranded as Bailey Point Assisted Living at Plattsmouth


ABOUT SAGORA SENIOR LIVING

Sagora Senior Living is among the nation’s Top-50 senior housing providers and is built upon a Resident First philosophy. The company operates 61 senior living communities with Cottages, Independent Living, Assisted Living and Memory Care living options. Sagora Senior Living’s communities span 12 states: Texas, California, Oklahoma, Illinois, New York, Ohio, West Virginia, Florida, North Dakota, Nebraska, Alabama and Mississippi. For additional information, please visit Sagora.com.

Share article on social media or email:

Apex Physics Partners Named to Fortune Best Workplaces in Health Care™ 2022


News Image

“We are honored to receive the designation of being one of the Best Workplaces in Health Care. We’ve made the best places to work list for the second year in a row, which is an incredible honor.” – Michael Curry, Jr., CEO of Apex Physics Partners “

Apex Physics Partners, the largest outsourced medical physics services company in North America, today announced it has been named by Fortune and Great Place to Work® as one of the 2022 Best Workplaces in Health Care™. Apex won in the small-to-medium companies category, and received this prestigious award based on an analysis of survey responses from over 161,000 current employees in the health care industry. In that survey, 91% of Apex employees said it is a great place to work, which is 34 points higher than the average U.S. company.

Michael Curry, Jr., CEO of Apex Physics Partners, said, “We are honored to receive the designation of being one of the Best Workplaces in Health Care. We’ve made the best places to work list for the second year in a row, which is an incredible honor. This is my favorite recognition that our company has received because it is by the employees, for the employees. Through a period of incredible business growth, we’ve continued to reward, recognize and delight our team. This is no small feat in today’s climate, as we’ve been living through periods such as the Great Resignation. Thank you to the team for making this possible. I couldn’t be more excited for another year of excellence.”

Apex’s mission is to transform the health and safety of its communities by providing comprehensive medical physics and radiation safety solutions to its clients. The company is passionate about creating meaningful and helpful relationships with clients by providing world-class services and support that put patients first. Whether ensuring all equipment is operating properly, to managing radiation safety to offering the best radiation oncology physics for cancer patients, Apex is committed to providing the “gold standard” in medical physics and radiation safety solutions.

The Fortune Best Workplaces in Health Care list is highly competitive. Great Place to Work, the global authority on workplace culture, selected the list using rigorous analytics and confidential employee feedback. Companies were only considered if they are a Great Place to Work-Certified™ organization. Great Place to Work is the only company culture award in America that selects winners based on how fairly employees are treated. Companies are assessed on how well they are creating a great employee experience that cuts across race, gender, age, disability status, or any aspect of who employees are or what their role is.

“It is our honor to spotlight the Best Workplaces in Health Care,” says Michael C. Bush, CEO of Great Place to Work. “Health care heroes have been on the front lines saving lives, and these organizations dug deep to tailor their support to the rapidly changing demands from the pandemic. We applaud their commitment to inclusive, high-trust cultures.”

Apex is hiring

Are you looking to grow your career at a company that puts its people first? Visit our careers page at: https://www.apexphysicspartners.com/careers/.

About Apex Physics Partners

Apex Physics Partners (http://www.apexphysicspartners.com) is a medical physics business services support organization. Through the Apex Physics Support Group, partner physics practices receive an array of support services, including client services, accounting/finance, sales, marketing, human resources, recruiting, information technology, data analytics, vendor management, legal and insurance.

About Great Place to Work Certification™

Great Place to Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place to Work-Certified.

About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting and insights they need to make data-driven people decisions. Everything they do is driven by the mission to build a better world by helping every organization become a great place to work For All™.

Learn more at greatplacetowork.com and on LinkedIn, Twitter, Facebook and Instagram.

Share article on social media or email:

Endpoint Clinical Selects Egnyte to Enhance IRT Audit Logs for Clinical Trials


Endpoint Clinical, a leader in global interactive response technology (IRT®) for clinical trials, and Egnyte, the secure platform for content collaboration and governance, today announced that Endpoint Clinical has partnered with Egnyte, providing a Google Cloud-compliant platform to establish a secure file server that can share IRT audit logs directly with Investigators post study close.

“Sponsors in regulatory inspections are cited frequently for not adhering to guidelines from health authorities, in regard to providing Investigators with direct audit log access for data oversight,” said Cat Hall, VP Data and Quality, at Endpoint Clinical. “IRT vendors are being asked to provide audit log extracts directly to Investigators to ensure data integrity. With limited means to share data outside of the traditional IRT system, we needed to work with a technology solution that could supply IRT audit logs straight to Investigator sites to ensure compliance. Egnyte was able to deliver on that and more.”

Egnyte helps life science organizations manage content-rich workflows that come with clinical studies, regulatory submissions, and more, maintaining compliance with industry regulations. Working with Egnyte, Endpoint Clinical has created a validated system that extracts IRT audit log data for each site and directly provisions the data files to investigators in the secure GxP-compliant platform.

“For highly regulated industries like life sciences, maintaining the validity of documents is essential,” said Ronen Vengosh, Vice President of Life Sciences at Egnyte. “Egnyte’s GxP-compliant solution gives these organizations the ability to manage their documents and maintain audit readiness with detailed audit trail reporting for data integrity.”

To learn more about how Endpoint Clinical has enhanced its IRT solution with Egnyte, visit http://www.endpointclinical.com/audit-data-management.

About Endpoint Clinical

Endpoint Clinical is an interactive response technology (IRT) systems and solutions provider that supports the life sciences industry. For over a decade, their team of professionals has been working to continuously evolve their suite of randomization and trial supply management (RTSM) technologies to help Sponsors achieve clinical trial success. Their dynamic IRT solution, PULSE®, for patient randomization and management, site management, and drug supply management and comprehensive clinical supplies management tool, DRIVE, have proven to maximize the supply chain, minimize operational costs, and ensure timely and accurate patient dosing. Endpoint is headquartered in Wakefield, MA, with offices across the US, EU, and Asia. http://www.endpointclinical.com

About Egnyte

Egnyte is the secure multi-cloud platform for content security and governance that enables organizations to better protect and collaborate on their most valuable content. Established in 2007, Egnyte has democratized cloud content security for more than 17,000 organizations, helping customers improve data security, maintain compliance, prevent and detect ransomware threats, and boost employee productivity on any app, any cloud, anywhere. For more information, visit http://www.egnyte.com.

Share article on social media or email:

Key Buffer Considerations for AAV Full Capsid Enrichment, Upcoming Webinar with Teknova, Hosted by Xtalks


A challenge in AAV production is the requirement for highly customized buffer formulations for each drug construct.

Successful gene therapy using AAV vectors requires high titers of functional virus. A challenge in AAV production is the requirement for highly customized buffer formulations for each drug construct. In particular, thorough consideration of the buffers utilized is required in order to achieve full capsid enrichment in the final anion-exchange chromatography polishing step due to the unique capsid and transgene combination.

Join Bella Neufeld, PhD, Director of Research and Development at Teknova, as she discusses the discreet, critical parameters that effect the downstream workflow for optimized AAV production.

Register for the live webinar, scheduled for Wednesday, November 2, 2022, at 1 p.m. EDT (10 a.m. PDT).

For more information, or to sign up for this event, visit Key Buffer Considerations for AAV Full Capsid Enrichment.

ABOUT TEKNOVA

Teknova is expediting clinical breakthroughs in life sciences by providing custom products and reagents for drug therapies, novel vaccines, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova’s proprietary processes enable the manufacture and delivery of high-quality, custom, made-to-order products with short turnaround times and at scale across all stages of development, including commercialization.

Contact:

Jennifer Henry

Tel: +1 (831) 313-1259

Email: jenn.henry@teknova.com    

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

American Physician Partners Appoints James Grimes as Senior Vice President, Chief Financial Officer


James Grimes, CFO, American Physician Partners

As we seek to build out our senior executive team with strong industry leaders, we feel James’s senior-level finance and accounting experience in healthcare will contribute to American Physician Partners’ ongoing growth and reputation as an industry leader.

American Physician Partners, LLC (“American Physician Partners” or “APP”), a leader in emergency medicine, hospital medicine, and critical care management services, is pleased to announce the appointment of James Grimes, CPA, to the role of senior vice president, chief financial officer effective October 20, 2022. Reporting to John Rutledge, president and CEO, Grimes will have responsibility for all accounting and financial activities of the company, including financial reporting, budget oversight, tax and treasury functions, growth forecasting, and revenue cycle management.

Grimes has more than 20 years of experience in healthcare accounting/finance. He is a growth-oriented leader, supporting more than $4B of acquisition and organic growth. He also has extensive external financial reporting experience, including 144A debt financing and SEC experience. He started his career in a senior audit role for Ernst & Young, LLP and has spent the last 18 years with Ardent Health Services, a Nashville-based owner/operator of hospitals and ancillary operations with $5B in net revenue. In his most recent role at Ardent as SVP finance, chief accounting officer, Grimes was responsible for internal/external financial reporting, corporate accounting, tax, government reimbursement, budget and capital planning, and revenue accounting/analysis. James received his BS in Accounting & Finance from the University of Tennessee, Knoxville, and his Master of Accountancy from the University of Virginia, Charlottesville.

“As we seek to build out our senior executive team with strong industry leaders, we feel James’s senior-level finance and accounting experience in healthcare will further American Physician Partners’ ability to exceed the expectations of our patients, providers, and hospital partners,” said John Rutledge, president and chief executive officer. “James’s strong financial expertise in high-growth environments will contribute to APP’s ongoing growth and reputation as an industry leader.”

About American Physician Partners

Headquartered in Brentwood, Tennessee, American Physician Partners was founded in 2015 to provide a better alternative to hospitals and healthcare systems for their clinical outsourcing needs. Since its inception, the company has grown to more than 160 practice sites and has become a recognized leader in the provision of exceptional emergency medicine, hospital medicine, and critical care management services to hospitals and healthcare systems nationwide. APP has earned its extensive growth by remaining true to its mission to support its providers and hospital partners in providing safe, compassionate, and efficient care to every patient, every time.

Share article on social media or email:

Codoxo’s First Customer Conference Showcased Advanced Healthcare AI Products for Payment Integrity and SIU Teams


News Image

“Our Customer Conference is about deepening relationships as well as recognizing and celebrating our Codoxo partners who are working every day to help make healthcare more affordable and effective for everyone.”

Codoxo, a trusted provider of healthcare artificial intelligence solutions for healthcare payers and agencies, hosted its inaugural Customer Conference from October 11 to 13, 2022. The three-day virtual event was extremely well attended by the Codoxo customer community of payment integrity and fraud, waste and abuse (FWA) users and leaders. Attendees were brought together with Codoxo subject matter experts to increase their understanding of the company’s Unified Cost Containment Platform, which delivers a complete suite of products enabling users across the entire payment spectrum to collaborate with new levels of visibility and transparency, all using the platform and claims data.

Attending customers represented a variety of healthcare companies, agencies, and plans in the medical, pharmacy, and dental fields. Live demonstrations of Codoxo products such as Fraud Scope, Provider Scope, and Audit Scope showcased the robust functionality of Codoxo’s highly visual and user-friendly AI tools built for Special Investigation Unit (SIU) and Payment Integrity (PI) teams. Attendees gleaned insights from product best practices and use cases from industry peers and had opportunities to candidly share challenges, ask questions, and provide feedback.

“Our customers are the reason that we’re here,” said Rena Bielinski, PharmD, AHFI, Codoxo’s Vice President of Customer Success. “We appreciate their incredible participation throughout our inaugural Customer Conference. Their valuable questions and feedback will continue to inform our product innovations so we can reduce FWA risk and the cost of healthcare.”

Highlights from the conference included:

  • Customer success – throughout the conference, Codoxo customers presented use cases, best practices, and outcomes of proactively detecting and managing FWA and PI programs using the Codoxo platform.
  • Product updates – including an overview of Codoxo’s product roadmap, recent improvements across detection, data, and reporting, such as a user experience (UX) enhancement with Audit Scope and new coding themes for provider educational purposes for Provider Scope.
  • Product innovation – the conference showcased some of the newly added innovations within the Unified Cost Containment platform that help our customers achieve significant outcomes. Codoxo continues to invest heavily in its products every year with customers obtaining access to all new enhancements as they are released.
  • Dedicated networking – events such as a speed networking session connected customers with their peers, as well as with the Codoxo teams who support their success every day.
  • Customer recognition – through the announcement of the Codoxo Rockstar Award, a special honor given to Codoxo’s top three Forensic AI platform users each year. The first winners will be announced in early 2023.

“Our Customer Conference is about deepening relationships as well as recognizing and celebrating our Codoxo partners who are working every day to help make healthcare more affordable and effective for everyone,” said Dr. Musheer Ahmed, CEO and founder of Codoxo.

Customers shared positive feedback about the event during the conference, noting it was well organized and offered valuable education and networking connections. Additionally, customers were exposed to and expressed an interest in some of the newer products from within the Unified Cost Containment platform that can help them break down silos across the Payment Integrity and SIU teams. Codoxo plans to host the customer conference annually, with the possibility of increased learning and use case sharing throughout the coming year.

About Codoxo

Codoxo’s mission is to make healthcare more affordable and effective for everyone and serves

as the premier provider of artificial intelligence-driven solutions and services that help healthcare companies and agencies proactively detect and reduce risks from fraud, waste, and abuse. The Codoxo Unified Cost Containment Platform helps clients manage costs across network management, clinical care, provider coding and billing, program integrity, and special investigation units. Our software-as-a-service applications are built on our proven Forensic AI Engine, which uses patented AI-based technology to identify problems and suspicious behavior far faster and earlier than traditional techniques. Our solutions are HIPAA-compliant and operate in a HITRUST-certified environment. For additional information, visit http://www.codoxo.com.

Share article on social media or email:

John Brooks Recovery Center expands evening hours for substance use disorder outpatient treatment


News Image

“By extending our outpatient treatment hours, we are increasing access to care for individuals suffering from an SUD and removing traditional barriers that would encourage ongoing treatment,” said Santillo.

John Brooks Recovery Center (JBRC) has received a $200,000 grant for Expanded Hours for Substance Use Disorder (SUD) Outpatient Programs from the State of New Jersey Department of Human Services (DHS), Division of Mental Health and Addiction Services (DMHAS).

The grant is being funded through the Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Opioid Response to Grants (SOR). JBRC is one of 10 grant recipients in the state.

Michael Santillo, Director II of John Brooks Recovery Center, A Member of AtlantiCare, says that with the addition of the expanded hours for SUD outpatient programs at JBRC’s Atlantic City location (1931 Bacharach Blvd.), individuals with an SUD will have access to standard and intensive outpatient services that include individual, group and family counseling sessions; psycho-education classes; medication assisted treatment; co-occurring medical and mental health screening, treatment and referral; medication monitoring; case management services; recovery support services, and overdose education and Naloxone distribution, provided Monday through Saturday from 5pm to 8pm in downtown Atlantic City.

According to the DMHAS, the expanded hours for SUD outpatient programs will provide increased access to outpatient treatment for individuals with an SUD.

“The purpose of outpatient services is to support, enhance and encourage the emotional development and the development of client’s life skills in order to maximize their individual functioning during alternate times from standard business hours (after hours and weekends),” according to the DMHAS. “These services are designed to preserve or improve current functioning, strengths and resources.”

“By extending our outpatient treatment hours, we are increasing access to care for individuals suffering from an SUD and removing traditional barriers that would encourage ongoing treatment,” said Santillo.

If you or someone you know is struggling with an addictive disorder, please call JBRC today. For Residential Services – Residential Detox/Withdrawal Management, Short-term Residential or Long-term Residential, please call 609-345-0110. For Outpatient Programs – Opioid Treatment Program, Intensive Outpatient Program or Standard Outpatient Program, please call 609-345-2020, extension 6182, 6180 or 6179.

About John Brooks Recovery Center

Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include Residential, Outpatient, Medication-assisted Recovery, Detox and Inmate Re-entry. To learn more, visit jbrcnj.org or visit them on Facebook @JohnBrooksRecoveryCenter.

About All Roads Recovery Community Center

All Roads Recovery Community Center, the community-based recovery arm of JBRC, helps anyone struggling with addiction navigate their next steps on the journey to recovery. All Roads currently offers a wide variety of Recovery Groups, as well as one-on-one coaching with Certified Peer Recovery Specialists (CPRS). To learn more, visit allroadsrecovery.org, call 609-457-1080 or visit them on Facebook @AllRoadsRCC.

Share article on social media or email:

Plant-Based Fat Alternative EPG Featured at Supply Side West 2022, Reduces the Caloric Footprint of Processed Foods Without Adverse Effects


News Image

“EPG not only serves as a fat alternative, reducing calories and saturated fat, but it actually improves the nutritional profile of many foods without compromising on taste, texture, and mouthfeel from the foods we love,” said David Rowe, founder, and president.

Epogee® LLC, maker of EPG—the category-defining ingredient that eliminates most calories from fat— announces its plant-based fat alternative has removed over 3 billion calories, in just four years, from the US food chain. EPG helps food manufacturers formulate better-for-you foods without sacrificing taste or texture, and without causing adverse side effects, across a variety of categories, including plant-based meats, chocolate confections, nut butters, salty and savory snacks, and baked goods. Products containing EPG will be featured at Supply Side West 2022 in Las Vegas, Nov. 2 and 3, in booth 1959, in the Food Ingredients North America section.

EPG is a modified plant-based oil and is the only fat alternative available that can cut up to 92% of calories from fat for each unit of fat replaced, with no digestive side effects. Its presence is growing with over 32 million servings to date, starting with just a handful of customers in 2019 to numerous product launches coming in 2023, according to David Rowe, founder, and president.

“We are excited by the rapid growth both Epogee and our customers are experiencing. In just two years, for example, N!CK’S Swedish-style Light Ice Creamä has gone from entering the market to performing as the third best-selling better-for-you pint ice cream,” said Rowe. “This growth is attributed to EPG’s ability to lower caloric density and saturated fat in products, without any tradeoffs when using EPG versus traditional fats or oils.”

Studies show that manufacturers and consumers are hungry for innovative solutions that greatly reduce calories and saturated fat. According to the CDC, approximately 60% of the American diet consists of processed foods. Four in ten American adults reported to have obesity, and rates are climbing nationwide, according to the State of Obesity 2022: Better Policies for a Healthier America. Epogee’s mission is to make food better with a sustainable plant-based fat alternative that fills a critical technical and commercial void.

“EPG not only serves as a fat alternative, reducing calories and saturated fat, but it actually improves the nutritional profile of many foods without compromising on taste, texture, and mouthfeel from the foods we love,” said Rowe.

In fact, the Epogee team will showcase low-calorie foods at the show, including:

· Chocolate confections

· Protein bars

· Popcorn

“We’re not out to eliminate all fat. Fat is required for a healthy diet, we want to eliminate the calories that come with consuming too many fat calories,” said Rowe. “We are proud of our progress in positively impacting obesity and other health challenges by reducing the caloric footprint of our nation’s food.”

Visit Epogee at booth #1959 or learn more about EPG at https://www.epogee.com.

null [About Epogee __title__ null]®

Epogee fulfills the greatest unmet need in food today: dramatically reduced calories without any compromise. Today’s food innovators are formulating with EPG in a variety of applications because of its groundbreaking capability to deliver the functional benefits of traditional fats while eliminating 92% of fat calories for each unit of fat replaced. Now manufacturers can make better-for-you foods with the great taste and texture consumers expect and love. Learn more about Epogee’s fat alternative, EPG, by visiting: https://www.epogee.com, https://www.linkedin.com/company/epogee-llc/ or @EPG4BetterFood

Share article on social media or email: